67% of 2,314 Long COVID patients surveyed reported symptoms of a dysregulated autonomic nervous system such as:
- A drop in blood pressure when standing
- Brain fog or cognitive disturbances
- Dizziness or light-headedness
- Heartbeat irregularities
- Gastrointestinal issues
- Tingling or numbness
- Bladder dysfunction
- Shortness of breath
- Sleep disturbances
- Chest pain
- Fatigue
This translates to 38 million Americans with Long COVID dysautonomia.
But there is a problem...🧵
"There are only 52 doctors in the US who are board-certified in autonomic disorders and fewer than 50 dysautonomia specialty centers throughout the US equipped to diagnose, treat, and study dysautonomia."
Furthermore, there are also no effective treatments for dysautonomia.
Existing medical centers are overwhelmed, forcing clinicians to "[turn] away new and even existing dysautonomia patients."
This is a heartfelt appeal to all the bright, dedicated medical students still exploring their specialty options: the Long COVID community urgently needs your skills, compassion, and innovation to address this growing crisis!
Please help us spread the word by sharing this content!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
In 2017, Alina Sternberg, a psychiatrist, was hit with crushing fatigue and brain fog.
Neurologists told her the symptoms were caused by depression.
"No, I can enjoy my life, and I know what depression is... I’m a psychiatrist!”
It took 6 years to discover the culprit...🧵
Alina's symptoms became progressively worse.
By 2023, she spent most of her days in bed.
Not only was she hit with soul-crushing fatigue, but her memory deteriorated.
One day,she forgot her way home, a place she had lived for 20 years.
Alina asked a colleague at the hospital where she worked if he would check to see if she had autoantibodies in her blood that might be attacking her brain.
He told her, "That is impossible because you aren't psychotic.”
Patients with atopic dermatitis are at increased risk of having severe depression.
A new study discovered the inflammatory link and new treatment approach...🧵
Proteomic analysis of 353 serum proteins was conducted on healthy controls and patients with either:
- Major depressive disorder (MDD)
- atopic dermatitis
- psoriasis
The inflammatory profile of those with MDD aligned most closely with atopic dermatitis.
(Both showed strong Th2 (T helper type 2) immune activation)
Computational (in silico) simulations were used to predict which drug might reverse this immune signature.
The IL-4/IL-13 inhibitor dupilumab (Dupixent, used for AD) reversed the MDD inflammatory signature more effectively than other agents tested (e.g., cyclosporine).
If this were a healthy brain would light up evenly.
But the brains of Long COVID patients light up in patches...🧵
\ The Discovery:
Researchers from the Department of Nuclear Medicine at Université de Lorraine in Nancy, France, intravenously injected a radioactive tracer into participants with Long COVID and healthy controls.
\ How 18F-FDG Works:
The tracer, 18F fluorodeoxyglucose (18F-FDG), is structurally similar to glucose, a sugar molecule transported into neurons from the bloodstream.
Once 18F-FDG is transported into neurons, it becomes trapped.
Here, the fluorine-18 isotopes decay, emitting light detected by the PET (positron emission tomography) scanner.
Neuropsychiatric symptoms, like OCD, can abruptly occur due to a dysregulated immune response to an infection.
Can depleting the antibody-producing immune cells be an effective form of treatment?
Here are the surprising results...🧵
Brain Inflammation Collaborative and Stanford researcher, Dr. Denise Calaprice, together with others at Stanford’s Immune Behavioral Health team, recently published a paper showing that 16 out of 23 (70%) patients with autoimmune OCD had "an unequivocal recovery following treatment with rituximab" (with and w/o co-administration of immune modulators).